| Product Code: ETC7647290 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, Israel continued to receive Capecitabine import shipments mainly from Switzerland, UK, Belgium, USA, and Germany. The low Herfindahl-Hirschman Index (HHI) indicates a competitive market with no dominant supplier. Despite a negative compound annual growth rate (CAGR) of -2.14% from 2020 to 2024, the slight improvement in the growth rate from 2023 to 2024 at -0.41% suggests a potential stabilization in the market. Israel`s reliance on diverse sources for Capecitabine imports reflects a strategic approach to ensure a steady supply of this important pharmaceutical product.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Capecitabine Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Capecitabine Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Capecitabine Market - Industry Life Cycle |
3.4 Israel Capecitabine Market - Porter's Five Forces |
3.5 Israel Capecitabine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 Israel Capecitabine Market Revenues & Volume Share, By Drug Formulation, 2021 & 2031F |
4 Israel Capecitabine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Israel |
4.2.2 Growing demand for oral chemotherapy drugs like capecitabine |
4.2.3 Advancements in cancer treatment leading to increased usage of capecitabine |
4.3 Market Restraints |
4.3.1 Stringent regulations and approval processes for pharmaceuticals in Israel |
4.3.2 Competition from other oral chemotherapy drugs in the market |
5 Israel Capecitabine Market Trends |
6 Israel Capecitabine Market, By Types |
6.1 Israel Capecitabine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Israel Capecitabine Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 Israel Capecitabine Market Revenues & Volume, By Colon Cancer, 2021- 2031F |
6.1.4 Israel Capecitabine Market Revenues & Volume, By Rectal Cancer, 2021- 2031F |
6.1.5 Israel Capecitabine Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.1.6 Israel Capecitabine Market Revenues & Volume, By Gastric Cancer, 2021- 2031F |
6.2 Israel Capecitabine Market, By Drug Formulation |
6.2.1 Overview and Analysis |
6.2.2 Israel Capecitabine Market Revenues & Volume, By Tablets, 2021- 2031F |
6.2.3 Israel Capecitabine Market Revenues & Volume, By Capsules, 2021- 2031F |
7 Israel Capecitabine Market Import-Export Trade Statistics |
7.1 Israel Capecitabine Market Export to Major Countries |
7.2 Israel Capecitabine Market Imports from Major Countries |
8 Israel Capecitabine Market Key Performance Indicators |
8.1 Patient adherence rate to capecitabine treatment |
8.2 Number of oncologists prescribing capecitabine |
8.3 Rate of adoption of capecitabine in different cancer types |
8.4 Average duration of capecitabine treatment per patient |
9 Israel Capecitabine Market - Opportunity Assessment |
9.1 Israel Capecitabine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 Israel Capecitabine Market Opportunity Assessment, By Drug Formulation, 2021 & 2031F |
10 Israel Capecitabine Market - Competitive Landscape |
10.1 Israel Capecitabine Market Revenue Share, By Companies, 2024 |
10.2 Israel Capecitabine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here